GERMANTOWN, Md.--(BUSINESS WIRE)--Avalon Pharmaceuticals, Inc. (Nasdaq: AVRX), today announced that Kenneth C. Carter, Ph.D., President and CEO, is scheduled to provide an update on the Company at the Lazard Capital Markets Healthcare Conference. The conference will be held at the New York Palace Hotel in New York, NY, on November 27-28. Dr. Carter is scheduled to present on Wednesday, November 28, at 8:30 am.
